A composite transposon associated with erythromycin and clindamycin resistance in group B Streptococcus

Journal of Medical Microbiology

Volumn 56, Issue 7, 2007, Pages 947-955

  Puopolo, Karen M ^a,b   Klinzing, David C ^a,b   Lin, Michelle P ^a,d   Yesucevitz, Derek L ^a   Cieslewicz, Michael J ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHROMOSOMAL LOCALIZATION; ERMB GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; SEROTYPING; SOUTHERN BLOTTING; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; TRANSPOSON; UNITED STATES;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BLOTTING, SOUTHERN; CHROMOSOME WALKING; CLINDAMYCIN; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; HUMANS; INFANT, NEWBORN; METHYLTRANSFERASES; MOLECULAR SEQUENCE DATA; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEQUENCE ANALYSIS, DNA; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

EID: 34447262072     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47131-0     Document Type: Article

References (40)

1. Andrews, J. I., Diekema, D. J., Hunter, S. K., Rhomberg, P. R., Pfaller, A., Jones, R. N. & Doern, G. V. (2000). Group B streptococci causing neonatal bloodstream infection, antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol 183, 859-862.
2. Arpin, C., Daube, H., Tessier, F. & Quentin, C. (1999). Presence of mefA and mefE genes in Streptococcus agalactiae. Antimicrob Agents Chemother 43, 944-946.
3. Banks, D. J., Porcella, S. F., Barbian, K. D., Martin, J. M. & Musser, J. M. (2003). Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus. J Infect Dis 188, 1898-1908.
4. Betriu, C., Gomez, M., Sanchez, A., Cruceyra, A., Romero, J. & Picazo, J. J. (1994). Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 38, 2183-2186.
5. Blumberg, H. M., Stephens, D. S., Modansky, M., Erwin, M., Elliot, J., Facklam, R. R., Schuchat, A., Baughman, W. & Farley, M. M. (1996). Invasive group B streptococcal disease, the emergence of serotype V. J Infect Dis 173, 365-373.
6. Centers for Disease Control and Prevention (CDC) (1996). Prevention of perinatal group B streptococcal disease, a public health perspective. MMWR Recomm Rep 45, 1-24.
7. Centers for Disease Control and Prevention (CDC) (2002). Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51, 1-22.
8. Chaffin, D. O. & Rubens, C. E. (1998). Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. Gene 219, 91-99.
9. Chatellier, S., Ramanantsoa, C., Harriau, P., Rolland, K., Rosenau, A. & Quentin, R. (1997). Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis. J Clin Microbiol 35, 2573-2579.
10. Chen, K. T., Puopolo, K. M., Eichenwald, E. C., Onderdonk, A. B. & Lieberman, E. (2005). No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. Am J Obstet Gynecol 192, 1167-1171.
11. Croak, A., Abate, G., Goodrum, K. & Modrzakowski, M. (2003). Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio. Am J Obstet Gynecol 188, 1148-1150.
12. Culebras, E., Rodriguez-Avial, I., Betrie, C., Redondo, M. & Picazo, J. J. (2002). Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob Agents Chemother 46, 1574-1576.
13. de Azavedo, J. C. S., McGavin, M., Duncan, C., Low, D. E. & McGeer, A. (2001). Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45, 3504-3508.
14. Diekema, D. J., Andrews, J. I., Huynh, H., Rhomberg, P. R., Doktor, S. R., Beyer, J., Shortridge, V. D., Flamm, R. K., Jones, R. N. & Pfaller, M. A. (2003). Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol 41, 2659-2661.
15. Fernandez, M., Hickman, M. K. & Baker, C. J. (1998). Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 42, 1517-1519.
16. Framson, P. E., Nittayajarn, A., Merry, J., Youngman, P. & Rubens, C. E. (1997). New genetic techniques for group B streptococci, high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917. Appl Environ Microbiol 63, 3539-3547.
17. Giovanetti, E., Brenciani, A., Vecchi, M., Manzin, A. & Varaldo, P. E. (2005). Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes. J Antimicrob Chemother 55, 445-451.
18. Heelan, J. S., Hasenbein, M. E. & McAdam, A. J. (2004). Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol 42, 1263-1264.
19. Junop, M. S. & Haniford, D. B. (1997). Factors responsible for target site selection in Tn10 transposition, a role for the DDE motif in target DNA capture. EMBO J 16, 2646-2655.
20. Kohli, A., Griffiths, S., Palacios, N., Twyman, R. M., Vain, P., Laurie, D. A. & Christou, P. (1999). Molecular characterization of transforming plasmid rearrangements in transgenic rice reveals a recombination hotspot in the CaMV 35S promoter and confirms the predominance of microhomology mediated recombination. Plant J 17, 591-601.
21. Lavigne, J. P., Vergunst, A. C., Bourg, G. & O'Callaghan, D. (2005). The IncP island in the genome of Brucella suis 1330 was acquired by site-specific integration. Infect Immun 73, 7779-7783.
22. LeBlanc, D. J., Lee, L. N. & Abu-Al-Jaibat, A. (1992). Molecular, genetic, and functional analysis of the basic replicon of pVA380-1, a plasmid of oral streptococcal origin. Plasmid 28, 130-145.
23. Limansky, A. S., Sutich, E. G., Guardati, M. C., Toresani, I. E. & Viale, A. M. (1998). Genomic diversity among Streptococcus agalactiae isolates detected by a degenerate oligonucleotide-primed amplification assay. J Infect Dis 177, 1308-1313.
24. McDougal, L. K., Tenover, F. C., Lee, L. N., Rasheed, J. K., Patterson, J. E., Jorgensen, J. H. & LeBlanc, D. J. (1998). Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 42, 2312-2318.
25. Morikawa, Y., Kitazato, M., Katsukawa, C. & Tamaru, A. (2003). Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan. J Infect Chemother 9, 131-133.
26. Paoletti, L. J., Bradford, J. & Paoletti, L. C. (1999). A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts. J Clin Microbiol 37, 3759-3760.
27. Pearlman, M. D., Pierson, C. L. & Faix, R. G. (1998). Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 92, 258-261.
28. Poyart, C., Quesne, G., Acar, P., Berche, P. & Trieu-Cuot, P. (2000). Characterization of the Tn916-like transposon Tn3872 in a strain of Abiotrophia defectiva (Streptococcus defectivus) causing sequential episodes of endocarditis in a child. Antimicrob Agents Chemother 44, 790-793.
29. Puopolo, K. M., Madoff, L. C. & Eichenwald, E. C. (2005). Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115, 1240-1246.
30. Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J. & Seppala, H. (1999). Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 43, 2823-2830.
31. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
32. Scott, J. R., Bringel, F., Marra, D., Van Alstine, G. & Rudy, C. K. (1994). Conjugative transposition of Tn916: preferred targets and evidence for conjugative transfer of a single strand and for a double-stranded circular intermediate. Mol Microbiol 11, 1099-1108.
33. Seppala, H., He, Q., Osterblad, M. & Huovinen, P. (1994). Typing of group A streptococci by random amplified polymorphic DNA analysis. J Clin Microbiol 32, 1945-1948.
34. Snoek, M., Teushcer, C. & van Vugt, H. (1998). Molecular analysis of the major MHC recombinational hot spot located within the G7c gene of the murine class III region that is involved in disease susceptibility. J Immunol 160, 266-272.
35. Takeuchi, K., Tomita, H., Fujimoto, S., Kudo, M., Kuwano, H. & Ike, Y. (2005). Drug resistance of Enterococcus faecium clinical isolates and the conjugative transfer of gentamicin and erythromycin resistance traits. FEMS Microbiol Lett 243, 347-354.
36. Tettelin, H., Masignani, V., Cieslewicz, M. J., Eisen, J. A., Peterson, S., Wessels, M. R., Paulsen, I. T., Nelson, K. E., Margarit, I. & other authors (2002). Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A 99, 12391-12396.
37. Tettelin, H., Masignani, V., Cieslewicz, M. J., Donati, C., Medini, D., Ward, N. L., Angiuoli, S. V., Crabtree, J., Jones, A. L. & other authors (2005). Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial 'pan-genome'. Proc Natl Acad Sci U S A 102, 13950-13955.
38. Tomich, P. K., An, F. Y. & Clewell, D. B. (1980). Properties of erythromycin-inducible transposon Tn917 in Streptococcus faecalis. J Bacterid 141, 1366-1374.
39. Weiser, J. N. & Rubens, C. E. (1987). Transposon mutagenesis of group B streptococcus β-hemolysin biosynthesis. Infect Immun 55, 2314-2316.
40. Whittle, G. & Salyers, A. A. (2002). Bacterial transposons, an increasingly diverse group of elements. In Modern Microbial Genetics, 2nd edn, pp. 385-427. Edited by U. N. Streips & R. E. Yasbin. New York: Wiley-Liss.